Market News AIOpen the app

Mizuho Securities changed Surgery Partners' rating to Neutral and set a price target of $25.

OpinionRead the original at marketscreener.com
Bad for SGRY

Mizuho lowered its view of Surgery Partners from Outperform to Neutral and set a $25 share target, a negative signal. The note also mentions recent third-quarter results and a proposed merger, but gives no details that change the rating's message.

SGRY · Surgery Partners, Inc.

AI read · Bad for SGRY

The AI's read

That gives a less favorable signal about Surgery Partners than Mizuho's earlier view. The note mentions recent quarterly results and a proposed merger to take the company off the stock market, but gives no details about either. Those mentions do not counter the lower rating.

Get alerts for SGRY

Follow Surgery Partners, Inc. (SGRY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SGRY
Free on the App Store and Google Play, or on the web.